logo
  • About Initiator Pharma
    • Mission
    • Scientific and Clinical Advisory Board
    • Goals, strategy and business model
    • CEO Letter
    • History
  • Science
    • Pipeline
      • IPED2015 Clinical Program
      • IP2018 Clinical Program
      • IPTN2021 Clinical Program
      • IPNP2015 Program* (preclinical)
      • IPDP2015 Program* (preclinical)
    • Technology & Therapeutic Areas
      • Erectile Dysfunction
      • Depression
      • Trigeminal Neuralgia
  • Governance
    • General Meetings
    • Management
    • Board of Directors
    • Auditing
    • Articles of Association
    • Remuneration and incentive program
  • Investors
    • Investment case
    • Reports and Presentations
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser
  • Media
    • Press Releases
    • Event Calendar
    • Subscribe
  • Contact
Loading..

Reports and Presentations

Financial reports
  • All categories
  • Presentations
2020
  • 2022
  • 2021
  • 2019
  • 2018
  • 2017
  • All years
English
  • English
  • Swedish
  • All languages
Regulatory
November 20, 2020

Initiator Pharma: INITIATOR PHARMA: Q3 2020 report

Financial HighlightsInitiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016.Third…

Read more
Regulatory
August 21, 2020

Initiator Pharma: INITIATOR PHARMA: H1 2020 report

Financial HighlightsInitiator Pharma A/S is a Danish registered company, and is reporting its financial situation in Danish kroner (DKK). Initiator Pharma A/S was registered on May 2, 2016. Second…

Read more
Regulatory
May 22, 2020

Initiator Pharma: INITIATOR PHARMA: 1 QUARTER REPORT 2020

Clinical progress and expanded pipeline

Read more
Regulatory
April 27, 2020

Annual report 2019 for Initiator Pharma A/S

Initiator Pharma’s annual report for 2019 is now available on the company’s home page

http://initiatorpharma.com/investors/financial-reports/

Read more
Regulatory
February 21, 2020

Initiator Pharma: INITIATOR PHARMA: YEAR END REPORT 2019

Fourth Quarter (2019-10-01 – 2019-12-31) Net revenues were TDKK 0 (0) EBIT was TDKK -2,503 (-2,508) Earnings per share was DKK -0.09 (-0.00) Full Year (2019-01-01 – 2019-12-31) Net revenues were…

Read more
  • Investors
    • Investment case
    • Reports and Presentations
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser

Share

Read more
Initiator Pharma logo
About Initiator Pharma
  • Mission
  • Scientific and Clinical Advisory Board
  • Goals, strategy and business model
  • CEO Letter
  • History
Science
  • Pipeline
    • IPED2015 Clinical Program
    • IP2018 Clinical Program
    • IPTN2021 Clinical Program
    • IPNP2015 Program* (preclinical)
    • IPDP2015 Program* (preclinical)
  • Technology & Therapeutic Areas
    • Erectile Dysfunction
    • Depression
    • Trigeminal Neuralgia
Governance
  • General Meetings
  • Management
  • Board of Directors
  • Auditing
  • Articles of Association
  • Remuneration and incentive program
Investors
  • Investment case
  • Reports and Presentations
  • The Share
  • Ownership Structure
  • Analyst and Media Coverage
  • Financial Calendar
  • Prospectuses
  • Press Releases
  • Subscribe
  • Certified Adviser
Media
  • Press Releases
  • Event Calendar
  • Subscribe
Contact

Share

Read more
  • Cookies
  • Privacy